USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$110.39M
Market Cap
-
P/E Ratio
-0.91
EPS
$3.72
52 Week High
$1.33
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $37M |
Total Revenue | $58M |
Cost Of Revenue | $21M |
Costof Goods And Services Sold | $21M |
Operating Income | -$110M |
Selling General And Administrative | $88M |
Research And Development | $57M |
Operating Expenses | $147M |
Investment Income Net | - |
Net Interest Income | -$11M |
Interest Income | $2.7M |
Interest Expense | $9.9M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4.5M |
Income Before Tax | -$121M |
Income Tax Expense | $312K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$121M |
Comprehensive Income Net Of Tax | - |
Ebit | -$109M |
Ebitda | -$104M |
Net Income | -$46M |
Field | Value (USD) |
---|---|
Total Assets | $144M |
Total Current Assets | $90M |
Cash And Cash Equivalents At Carrying Value | $57M |
Cash And Short Term Investments | $57M |
Inventory | $14M |
Current Net Receivables | $10M |
Total Non Current Assets | $54M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $32M |
Intangible Assets Excluding Goodwill | $32M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $8.3M |
Other Non Current Assets | - |
Total Liabilities | $146M |
Total Current Liabilities | $71M |
Current Accounts Payable | $32M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $3.2M |
Total Non Current Liabilities | $74M |
Capital Lease Obligations | $17M |
Long Term Debt | $58M |
Current Long Term Debt | $625K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $76M |
Other Current Liabilities | $36M |
Other Non Current Liabilities | $1.8M |
Total Shareholder Equity | $23M |
Treasury Stock | - |
Retained Earnings | -$741M |
Common Stock | $28K |
Common Stock Shares Outstanding | $21M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$80M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $4.5M |
Capital Expenditures | $15M |
Change In Receivables | - |
Change In Inventory | -$4.2M |
Profit Loss | - |
Cashflow From Investment | -$15M |
Cashflow From Financing | $71M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $4.7M |
Dividend Payout Common Stock | $4.7M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$121M |
Field | Value (USD) |
---|---|
Gross Profit | $37M |
Total Revenue | $58M |
Cost Of Revenue | $21M |
Costof Goods And Services Sold | $21M |
Operating Income | -$110M |
Selling General And Administrative | $88M |
Research And Development | $57M |
Operating Expenses | $147M |
Investment Income Net | - |
Net Interest Income | -$11M |
Interest Income | $2.7M |
Interest Expense | $9.9M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4.5M |
Income Before Tax | -$121M |
Income Tax Expense | $312K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$121M |
Comprehensive Income Net Of Tax | - |
Ebit | -$109M |
Ebitda | -$104M |
Net Income | -$46M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.